Expanding Public‐Private Collaborations to Enhance Cancer Drug Development: A Report of the Institute of Medicine's Workshop Series, “Implementing a National Cancer Clinical Trials System for the 21st Century”

Since their inception in the 1950s, the National Cancer Institute‐funded cancer cooperative groups have been important contributors to cancer clinical and translational research. In 2010, a committee appointed by the Institute of Medicine (IOM) of the National Academy of Sciences completed a consens...

Full description

Saved in:

Bibliographic Details
Published in:	The oncologist (Dayton, Ohio) Vol. 19; no. 11; pp. 1179 - 1185
Main Authors:	Bertagnolli, Monica M., Canetta, Renzo, Nass, Sharyl J.
Format:	Journal Article
Language:	English
Published:	Durham, NC, USA AlphaMed Press 01-11-2014
Subjects:	Antineoplastic Agents Biomedical Research - organization & administration Biomedical Research - trends Clinical trials Clinical Trials as Topic Drug development Drug Discovery - organization & administration Humans Institute of Medicine National Cancer Institute National Cancer Institute (U.S.) New Drug Development and Clinical Pharmacology Public-Private Sector Partnerships - organization & administration Societies, Scientific Translational Medical Research - organization & administration Translational Medical Research - trends United States United States Clinical trials National Cancer Institute Institute of Medicine Drug development
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!